Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
PROK ProKidney
- 1.610
- +0.010+0.63%
Close Feb 14 16:00 ET
- 1.600
- -0.010-0.62%
Post 17:39 ET
206.03MMarket Cap-2.98P/E (TTM)
1.670High1.565Low203.56KVolume1.610Open1.600Pre Close328.53KTurnover0.29%Turnover RatioLossP/E (Static)127.97MShares4.44052wk High-0.21P/B112.11MFloat Cap1.34052wk Low--Dividend TTM69.63MShs Float14.190Historical High--Div YieldTTM6.56%Amplitude1.120Historical Low1.613Avg Price1Lot Size
About ProKidney Company
ProKidney Corp（formerly Social Capital Suvretta Holdings Corp. III） is an advanced biotechnology company founded by innovators. The company was founded on 2015, is a pioneer in the innovative treatment of chronic kidney disease (CKD) through cell therapy.
Company Profile
SymbolPROK
Company NameProKidney
Listing DateJun 30, 2021
Founded2015
CEODr. Bruce Culleton, M.D.
MarketNASDAQ
Employees163
Fiscal Year Ends12-31
Address2000 Frontis Plaza Boulevard,Suite 250
CityWinston-Salem
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27103
Phone1-336-999-7028
Websitehttps://www.prokidney.com/
Company Executives
- Name
- Position
- Salary
- Dr. Bruce Culleton, M.D.
- Chief Executive Officer and Director
- 8.71M
- Todd C. Girolamo, J.D.,M.B.A.
- Chief Legal Officer
- 2.30M
- James Coulston, C.P.A.
- Chief Financial Officer and Principal Accounting Officer
- 2.29M
- Dr. Darin J. Weber, PhD
- Chief Regulatory Officer and Senior Vice President, Global Regulatory, Quality Management and Commercial
- --
- Lucio Tozzi
- Senior Vice President, Global Clinical Operations
- --
- Dr. Ulrich Ernst, PhD
- Executive Vice President, Technical Operations
- --
- Pablo Legorreta
- Chairman of the Board
- 434.10K
- Dr. Alan M. Lotvin, M.D.
- Independent Director
- 423.60K
- Jennifer A. Fox
- Independent Director
- 749.64K
- William F. Doyle
- Independent Director
- 413.10K
- Jose Ignacio Jimenez Santos
- Independent Director
- 404.60K
- Dr. Uma Sinha, PhD
- Independent Director
- 410.60K
- Dr. Brian J.G. Pereira,M.D.
- Independent Director
- 421.10K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.